<GlossaryTerm id="CDR0000321363"><TermName>CT-2106</TermName><TermDefinition><DefinitionText>A form of the anticancer drug camptothecin that may have fewer side effects and work better than camptothecin. It is being studied in the treatment of cancer. It is a type of DNA topoisomerase inhibitor. Also called polyglutamate camptothecin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>CT-2106</SpanishTermName><SpanishTermDefinition><DefinitionText>Tipo de camptotecina, un medicamento contra el cáncer que puede tener menos efectos secundarios y funcionar mejor que la camptotecina. Está en estudio para el tratamiento de cáncer. Es un tipo de inhibidor de la topoisomerasa del ADN. También se llama poliglutamato de camptotecina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-07-26</DateFirstPublished><DateLastModified>2007-05-17</DateLastModified></GlossaryTerm>
